Zafirova Zdravka, Vázquez-Narváez Karina G, Borunda Delia
Section of Critical Care, Department of Cardiovascular Surgery, Mount Sinai Hospital System, 1 Gustave L. Levy Place, Mail Box 1028, New York, NY 10029, USA.
Department of Anesthesiology and Perioperative Medicine, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Vaco de Quiroga #15, Col. Belisario Dominguez Sección XVI, Mexico City 14080, Mexico.
Anesthesiol Clin. 2018 Dec;36(4):663-675. doi: 10.1016/j.anclin.2018.07.012.
Increasingly complex medication regimens for many comorbidities in patients for planned surgical and procedural interventions necessitate detailed preoperative evaluation of the pharmacologic therapy, including the indications, the specific drugs, and dosing amount and interval. The implications of continuing or withholding these agents in the perioperative period need to be elucidated, as well as the risks of interactions and side effects. A comprehensive plan of the management of the therapeutic agents should be devised during the preoperative visit, with input from all relevant specialists, and clearly communicated to the patients in a format that ensures their comprehension and consistent compliance.
对于计划进行手术和其他操作干预的患者,因多种合并症而采用的药物治疗方案日益复杂,这就需要对药物治疗进行详细的术前评估,包括用药指征、具体药物、剂量和给药间隔。需要阐明在围手术期继续使用或停用这些药物的影响,以及药物相互作用和副作用的风险。术前访视期间,应在所有相关专科医生的参与下,制定一份治疗药物管理的全面计划,并以确保患者理解并能持续依从的形式清楚地告知患者。